COMBINATION OF ACE INHIBITOR WITH AGONIST OF I1 -IMIDAZOLINE RECEPTORS: NEW OPPORTUNITIES FOR ANTIHYPERTENSIVE THERAPY

COMBINATION OF ACE INHIBITOR WITH AGONIST OF I1 -IMIDAZOLINE RECEPTORS: NEW OPPORTUNITIES FOR ANTIHYPERTENSIVE THERAPY

The number of patients with metabolic syndrome and obesity is continuously increasing. Specifics of arterial hypertension in obesity is related to activation of renin-angiotensin-aldosterone system and sympathetic system, inflammation, early and prominent target organs damage, which is significant t...

Full description

Bibliographic Details
Main Author:	S. V. Nedogoda
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2016-12-01
Series:	Российский кардиологический журнал
Subjects:	arterial hypertension metabolic syndrome insulin resistance perindopril moxonidine
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/994

Similar Items

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01)

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
by: D. V. Nebieridze, et al.
Published: (2015-12-01)

Moxonidine-based combination antihypertensive therapy in patients with metabolic syndrome
by: E. V. Tishina, et al.
Published: (2012-06-01)

Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01)

An imidazoline receptor agonist, moxonidine, in optimization of arterial hypertension treatment among postmenopausal women
by: A. B. Bakhshaliev, et al.
Published: (2006-02-01)

Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons
by: Yu. M. Lopatin
Published: (2006-06-01)

Features of antihypertensive therapy and real-world prescription of selective imidazoline receptor agonists in Russia vs other countries: STRAIGHT study data analysis
by: Alexandra O. Konradi, et al.
Published: (2021-04-01)

IMIDAZOLINE RECEPTORS IN INSULIN SIGNALING AND METABOLIC REGULATION
by: Sun, Zheng
Published: (2007)

ADDITIONAL BENEFITS OF ANTIHYPERTENSIVE MOXONIDINE THERAPY IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION
by: E. N. Dudinskaya, et al.
Published: (2014-02-01)

Effectiveness and safety of the ACE inhibitor and diuretic combination in postmenopausal women with arterial hypertension
by: G. G. Semenkova, et al.
Published: (2011-06-01)

COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE
by: O. A. Ageenkova, et al.
Published: (2016-01-01)

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial
by: - Giuseppe Derosa, et al.
Published: (2009-03-01)

COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME
by: E. I. Mananko, et al.
Published: (2016-01-01)

COMBINATION ANTIHYPERTENSION THERAPY: TRIPLE FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS
by: O. D. Ostroumova, et al.
Published: (2017-02-01)

Combined antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: O. A. Ageenkova, et al.
Published: (2011-06-01)

Pharmacotherapy efficacy assessment in arterial hypertension with metabolic disturbances
by: A. A. Demin, et al.
Published: (2005-06-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01)

ADVANTAGES AND NOVELTY OF CLINICAL APPLICATION OF THE TRIPLE COMBINATION FOR ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA: ACE INHIBITOR PERINDOPRIL WITH ROSUVASTATIN AND INDAPAMIDE
by: M. L. Maksimov, et al.
Published: (2017-08-01)

Clinical and Pharmacological Approaches to the Prescription of Centrally Acting Antihypertensive Drugs for Uncontrolled Arterial Hypertension
by: A. V. Strygin, et al.
Published: (2020-11-01)

BLOOD PRESSURE VARIABILITY AS A NEW TARGET FOR ANTIHYPERTENSIVE THERAPY: FOCUS ON THE FIXED COMBINATION OF AMLODIPINE AND PERINDOPRIL ARGININ
by: V. M. Gorbunov
Published: (2012-10-01)

Perindopril metabolic effects and organo-protective action in metabolic syndrome patients
by: V. B. Mychka, et al.
Published: (2007-04-01)

Treatment of hypertension in overweight patients
by: V G Kukes, et al.
Published: (2015-09-01)

Отечественный и зарубежный опыт применения препарата Физиотенз® в лечении «заболеваний цивилизации»
by: А. А. Михайлов, et al.
Published: (2012-02-01)

Perindopril in treatment of patients with arterial hypertension and high cardiovascular risk
by: Сергей Владимирович Недогода, et al.
Published: (2009-06-01)

LIGAND OF PERIPHERAL IMIDAZOLINE RECEPTORS BASED ON AMIDES OF HETEROCYCLIC ACIDS C7070: EFFECT ON ISHEMIZED TISSUES
by: Anton Dovgan
Published: (2017-12-01)

Evaluation of the antihypertensive efficacy and safety of moxonidine in the treatment of uncomplicated hypertensive crisis
by: S N Tereshchenko, et al.
Published: (2013-03-01)

Antihypertensive efficacy of a fixed full-dose perindopril A-indapamide combination in patients with grades 2–3 arterial hypertension
by: T V Glukhova, et al.
Published: (2013-03-01)

THE EVALUATION OF ANTIHYPERTENSIVE EFFICACY OF ORALLY-DISPERSING FORM OF PERINDOPRIL IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: R. A. Khokhlov, et al.
Published: (2014-12-01)

Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach
by: Yu V Zhernakova, et al.
Published: (2015-03-01)

Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
by: S. V. Nedogoda, et al.
Published: (1970-01-01)

The effect of combined antihypertensive therapy on arterial wall rigidity in male patients with hypertension, obesity and obstructive sleep apnea
by: E M Elfimova, et al.
Published: (2016-12-01)

The effect of combined antihypertensive therapy on arterial wall rigidity in male patients with hypertension, obesity and obstructive sleep apnea
by: Elfimova E.M., et al.
Published: (2016-12-01)

The effect of combined antihypertensive therapy on left ventricular diastolic function in resting and postexercise patients with arterial hypertension
by: M. Yu. Kolesnyk
Published: (2015-04-01)

Pharmacodynamic and pharmacoeconomic aspects of application of antihypertensive preparations of various groups in patients with arterial hypertension
by: Kurkina T.V., et al.
Published: (2010-09-01)

Hypertension treatment features in perimenopausal women
by: Yu V Zhernakova, et al.
Published: (2014-03-01)

Combined antihypertensive therapy in treating patients with metabolic syndrome
by: V. B. Mychka, et al.
Published: (2008-06-01)

Perindopril - angiotensin-converting enzyme inhibitor is approved for usage
by: D A Napalkov
Published: (2014-12-01)

Arterial hypertension in women with climacteric syndrome
by: V. I. Podzolkov, et al.
Published: (2005-10-01)

The comparative analysis of therapy by «typical practice» and the fixed combination perindopril and indapamide an arterial hypertension with kidney insufficiency
by: S V Shiganov, et al.
Published: (2013-12-01)

The role of hypersympathycotony in development of arterial hypertensionin patients with metabolic syndrome: potential of pathogenetically sound therapy
by: A S Ametov, et al.
Published: (2004-12-01)